Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 6/20 | 0.47 |
| ▸ | ESR1 | P03372 | 5/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | GHSR | Q92847 | 11/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | DRD1 | P21728 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30645344 | 0.88 | ESR2 (0.51) | ESR2ESR1OPRK1GHSRDRD2 | |
| SCHEMBL24528881 | 0.88 | ESR2 (0.51) | ESR2ESR1OPRK1GHSRDRD2 | |
| SCHEMBL25896285 | 0.85 | ESR2 (0.50) | ESR2ESR1OPRK1GHSRDRD2 | |
| SCHEMBL3864665 | 0.82 | ESR2 (0.47) | ESR2ESR1GHSRDRD2DRD1 | |
| SCHEMBL8523114 | 0.80 | DRD2 (0.55) | ESR2ESR1OPRK1DRD2DRD1 | |
| SCHEMBL2081445 | 0.78 | ESR2 (0.49) | ESR2ESR1GHSR | |
| SCHEMBL31505332 | 0.78 | ESR2 (0.56) | ESR2ESR1GHSRDRD2DRD1 | |
| SCHEMBL30645355 | 0.78 | ESR2 (0.56) | ESR2ESR1GHSRDRD2DRD1 | |
| SCHEMBL24528817 | 0.78 | ESR2 (0.56) | ESR2ESR1GHSRDRD2DRD1 | |
| SCHEMBL31505408 | 0.78 | ESR2 (0.56) | ESR2ESR1GHSRDRD2DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012065527-A1 | COMPOUDS AND USES AS L-TYPE CALCIUM CHANNEL BLOCKER AND/OR ACETYLCHOLINESTERASE INHIBITOR THEREOF | 江苏先声药物研究有限公司 (CN) | 2012-05-24 | — | — | WO | disclosed |